Skip to content

Medium-term Venous Access in Congenital Heart Surgery

A Medium-term Venous Access Alternative in Infants Undergoing Congenital Heart Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00852488
Enrollment
50
Registered
2009-02-27
Start date
2009-03-31
Completion date
2010-01-31
Last updated
2017-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Surgery

Brief summary

This study is designed to evaluate medium-term central venous catheter placement in infants undergoing complex cardiac surgery using a new technique. This technique involves placement of the catheter into the inferior vena cava through a subcutaneous tunnel and through a tunnel between pericardium and diaphragm.

Interventions

PROCEDUREPlacement of transthoracic catheter

Placement of transthoracic catheter into the inferior vena cava

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Days to 365 Days
Healthy volunteers
No

Inclusion criteria

* Infants undergoing surgical correction or palliation of congenital heart disease via sternotomy * Age 0-365 days * Anticipated intensive care stay over 10 days * Need for central venous access or prolonged venous access

Exclusion criteria

* Presence of access that is likely to last more than 10 days at time of operation * Septic shock * Known inferior vena cava thrombosis * Operations not approached by sternotomy

Design outcomes

Primary

MeasureTime frame
Days of complication-free use. Morbidity (infection, malposition, bleeding, thrombosis, need for removal for catheter-related complication). Need for additional catheter placement or reintervention.Until catheter no longer needed; it is not anticipated that these remain longer than 2 weeks. Prior to discharge all will have been removed and final assessment of primary outcome will be obtained

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026